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ABSTRACT We present a single virion method to determine absolute distributions of copy number in the protein composition
of viruses and apply it to herpes simplex virus type 1. Using two-color coincidence ﬂuorescence spectroscopy, we determine the
virion-to-virion variability in copy numbers of ﬂuorescently labeled tegument and envelope proteins relative to a capsid protein
by analyzing ﬂuorescence intensity ratios for ensembles of individual dual-labeled virions and ﬁtting the resulting histogram of
ratios. Using EYFP-tagged capsid protein VP26 as a reference for ﬂuorescence intensity, we are able to calculate the mean and
also, for the ﬁrst time to our knowledge, the variation in numbers of gD, VP16, and VP22 tegument. The measurement of the
number of glycoprotein D molecules was in good agreement with independent measurements of average numbers of these
glycoproteins in bulk virus preparations, validating the method. The accuracy, straightforward data processing, and high
throughput of this technique make it widely applicable to the analysis of the molecular composition of large complexes in
general, and it is particularly suited to providing insights into virus structure, assembly, and infectivity.
INTRODUCTION
Viruses are large and sophisticated macromolecular com-
plexes, whose assembly is still poorly understood and whose
composition may vary from one particle to another. The
variation in the protein composition of virions may affect the
biological characteristics of different populations and may
determine important properties such as infectivity and the
ability to neutralize the virus with antibodies. Furthermore,
characterizing variability in the protein composition of
populations of virions produced during virus replication is
fundamental to understanding mechanisms of virus assembly
and packaging. To date, it has not been possible to explore
these relationships due to the lack of suitable methods for
assessing compositional heterogeneity at the single-particle
level. However, recently developed single-molecule ﬂuores-
cence methods (1) have offered the opportunity to study such
variation for large numbers of individual molecules or as-
semblies of molecules. Applying these techniques to virions
enables us to measure the extent to which individual virus
particles vary in terms of their compositional makeup. Such
information is not available from ensemble methods and
extends the application of single-molecule methods to the
virion-by-virion measurement of the variation in protein
distribution. We demonstrate here a single-virion ﬂuores-
cence spectroscopy method that facilitates the analysis of
tens of thousands of individual virus particles to accurately
examine both the mean number of proteins present per virion
and the variation of this protein composition in the popu-
lation. This method is applied to herpes simplex virus type
1 (HSV1), one of the largest and most complex virus struc-
tures known.
Herpesviruses are enveloped viruses containing asymmet-
ric structural features including an outer membrane and an
amorphous protein layer (tegument) inside the envelope that
makes analysis by x-ray crystallography or cryoelectron mi-
croscopy difﬁcult. The human herpesviruses are associated
with a wide range of diseases, including cold sores, genital
lesions, chicken pox, and glandular fever. All herpesviruses
share a common virion morphology: a double-stranded DNA
genome is contained within an icosahedral protein shell
(capsid), and this is surrounded by a layer of ;20 types of
tegument proteins and a lipid bilayer envelope containing 11
types of embedded viral glycoproteins (2,3). The 125-nm-
diameter capsid of HSV1 has been studied in detail by
cryoelectron microscopy, and its structure is known to 8.5-A˚
resolution (4). The tegument and envelope layers of HSV1
virions, 225 nm in diameter, have been observed to ;70-A˚
resolution by cryoelectron tomography (2). At this resolu-
tion, 600–750 spikes could be observed on the virion surface
but could not be identiﬁed as speciﬁc glycoproteins. Proteins
within the irregular tegument layer could not be resolved (2).
At present it is unclear how the assembly process of HSV is
regulated and how the virus ensures that all the virion
components are incorporated at the correct stoichiometries
into the mature virus particle. Due to the lack of detailed
structural information available for the irregular tegument
and envelope layers of the virus, there are currently no data
available on whether the protein composition of these layers
can vary considerably between virus particles or whether
tight regulation of copy number is important for virus
infectivity.
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The ﬂuorescently tagged capsid protein VP26 has previ-
ously been shown by confocal microscopy to be present at
homogenous levels within herpes virions (5,6). Homogeneous
expression of capsid proteins is expected because of the
regular geometry of the capsid, which can incorporate only a
ﬁxed number of its component proteins. Only one previous
study, however, has directly examined virion-to-virion vari-
ability in levels of a noncapsid protein. del Rio et al. (5)
measured the total ﬂuorescence from 200 individual puriﬁed
virions expressing green ﬂuorescent protein (GFP)-VP22 (a
tegument protein of the a-herpesvirus, pseudorabies virus) by
confocal microscopy. The authors make some incisive con-
clusions about the distributions of tegument proteins, which
are supported by our measurements and which we discuss
later in more detail. However, they do not attempt to deﬁne
these distributions in terms of absolute copy numbers, and
their sample sizes are quite limited by the labor-intensive
method used to collect data (in contrast to our method, which
can easily sample 10,000 virions, as detailed below).
The single-virion technique that we have developed
allows analysis of heterogeneity in the protein composition
of HSV1 virions by quantitative measurement of relative
numbers of ﬂuorescently labeled proteins present in indi-
vidual particles and can easily generate sample sizes of the
order of 10,000 virions; at a rate of 5–10 virions sampled per
second, 10,000 virions are measured in ;22 min. The
schematic of the apparatus is shown in Fig. 1. This method
involves detection of particles labeled with two different
ﬂuorophores that are excited independently in the focus of
two overlapped laser beams and the ﬂuorescence detected
simultaneously, as we recently demonstrated for single
molecules (7,8). Because the laser beam has a Gaussian
intensity proﬁle, there is signiﬁcant variation in ﬂuorescence
measured from ﬂuorophores passing through the beam at
different places. Passage of ﬂuorophores through the beam
center results in the brightest intensity measurements, but it
occurs less frequently than trajectories that pass through the
edges of the beam. Analyzing the ratio of ﬂuorescence
signals from two overlapping beams with similar intensity
proﬁles reduces the contribution of this spatial variation in
laser intensity to the measurements, allowing the relative
intensities of ﬂuorescence recorded from two different color
ﬂuorophores present in the same molecule, or complex
particle, to be compared (9,10). This is done by identifying
coincident ﬂuorescence bursts and then forming a histogram
of the ratio of ﬂuorescence for each burst. At the single-
molecule level, dimers and trimers can be distinguished by
the position of the peak in the ratio histogram (9,10). This
ratiometric method is similar to ﬂuorescence cross correla-
tion spectroscopy that also uses dual laser excitation (11,12)
but is performed on individual molecules and is based on
direct counting; the data are thresholded and the method
allows the stoichiometry and its variation to be determined
by ﬁtting of the ratio histograms.
By examining whole virions, we now extend this ratio-
metric approach to analysis of much larger and more complex
associations of labeled molecules. To analyze relative protein
levels, we made use of dual-labeled HSV1 particles, previ-
ously constructed for studies on HSV1 morphogenesis (13).
For the ﬁrst color channel we used virions expressing either
enhanced yellow ﬂuorescent protein (EYFP)-tagged capsid
protein VP26 or enhanced green ﬂuorescent protein (EGFP)-
tagged tegument proteins VP16 or VP22. For the second
color channel, virions were bound by Alexa-647-labeled anti-
bodies (LP2) directed against envelope glycoprotein D (gD).
By detecting only coincident events, free antibodies are auto-
matically distinguished from those bound to virions. Repre-
sentative data for the signals observed in the two channels are
FIGURE 1 Schematic of experimental apparatus.
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shown in Fig. 2. We used the peak positions in the ratio
histograms derived from such data to determine the number of
proteins per virion and the widths of the histograms to de-
termine the variation in the proteins per virion. This method is
general and offers the potential for studying variation in the
protein composition of other viruses and other complex mo-
lecular assemblies.
MATERIALS AND METHODS
Puriﬁcation of HSV1 virions
Recombinant HSV1 viruses that had been engineered to express
ﬂuorescently tagged capsid (VP26-YFP) (14) and tegument (VP16-GFP,
VP22-GFP) proteins (15,16) were used in all dual-labeling experiments.
These recombinant viruses all replicate as efﬁciently as wild-type virus and
incorporate the GFP-tagged proteins into virions normally (15–17). Virions
were puriﬁed according to the following procedure. Medium from infected
rodent ﬁbroblast (baby hamster kidney cells) was collected 2–3 days post-
infection and clariﬁed by centrifugation at 2500 rpm in a Mistral 6000 rotor
(MSE(UK) Limited, London, United Kingdom). Virus particles were pel-
leted from the supernatant by centrifugation for 2 h at 16,000 rpm in a
Beckman 19R rotor (Beckman, Fullerton, CA). Pellets were resuspended in
2 mL phosphate buffer saline (PBS) (NaCl, 150 mM; Na2HPO4, 10 mM;
NaN3, 2 mM; adjusted to pH 7.2; ﬁltered by a 0.02-mm mesh Anotop 25
inorganic membrane ﬁlter from Whatman International, Maidstone, England),
sonicated, and layered onto 30-mL Ficoll gradients (5%–15%) in PBS by
centrifugation for 1.5 h at 12,000 rpm in a Beckman SW28 rotor. The banded
virus was harvested from the gradient, diluted to 30 mL in PBS, and repelleted
by centrifugation for 2 h at 20,000 rpm in a Beckman SW28 rotor. Pellets were
resuspended in 500 mL of PBS and frozen at 70C in 50-mL aliquots. After
puriﬁcation, virus concentrations were estimated by counting negatively
stained particles in an electron microscope as previously described (18).
Preparation of ﬂuorescently labeled antibodies
Monoclonal antibody LP2 (which recognizes HSV glycoprotein D) was puri-
ﬁed from the tissue culture supernatant of hybridoma cells by immuno-
afﬁnity chromatography on a protein A sepharose column as previously
described (19). LP2 effectively neutralizes HSV1 (19). Puriﬁed antibody
concentrations were determined by measuring the optical density at 280 nm.
LP2 was labeled with the red ﬂuorophore Alexa-647 (Molecular Probes,
Eugene, OR) according to the protocol provided by the manufacturer (8).
The number of dye molecules per antibody was calculated from the optical
density at 650 nm. Average labeling levels were 8.9 dye molecules per
antibody for LP2-Alexa-647 so that with multiple ﬂuorophores per
antibody any possible environmental changes on binding to the virus are
minimized.
Virus-antibody binding reactions
Puriﬁed virus particles were diluted with PBS to concentrations between 2
and 20 pM (;109–1010 particles/mL) and total reaction volumes of 500 mL.
Virus samples were then sonicated for 20 s to prevent aggregation, and
debris was removed by pulse spinning in a microcentrifuge. Alexa-647-
labeled LP2 was added to virus particles at antibody/virion molar ratios of
1000:1. Reactions were incubated for 1 h at room temperature and then ﬁxed
by the addition of 37% formaldehyde (1% ﬁnal concentration) for 10 min at
room temperature. These conditions were conﬁrmed by plaque assay to
inactivate the virus, and the subsequent ﬂuorescence measurements were
made under containment level 1 conditions. Samples were transported be-
tween laboratories on ice and either used immediately (see below) or stored
frozen at 80C overnight.
Anti-gD binding curve
Virions were diluted to 10 pM in PBS, and different amounts of Alexa-647-
labeled LP2- immunoglobulin G (IgG) were added, ranging from 50 pM to 6
nM (5–600 times virion concentration). The ﬂuorescence background at
each antibody concentration was determined independently in a separate
experiment where no virus was added. All measurements were carried out at
room temperature. The mean diffusion time of a single virion was measured
to be 3 ms and the mean diffusion time for an antibody was 500 ms. We
collected data for 180 min with a 10-ms integration time longer than the
diffusion time. A threshold of 10 times higher than average background
was used at all antibody concentrations to identify single virions. For each
concentration of antibody, the brightness of labeled virions was estimated
by averaging the 1000 ﬂuorescence bursts of highest intensity. In this
experiment, a replication-defective gH-negative mutant of HSV1, named
HFEMdelUL22Z (20), was used. This virus was propagated in a helper cell
line, CR1, which supplies gH in trans (21). Previous studies have shown that
the absence of gH from HSV1 virions does not inﬂuence the amounts of
other glycoproteins, including gD, that are incorporated into virus particles
(20). Therefore, a gH-null virus was considered to be an appropriate mutant
to use for this analysis, which allowed these experiments to be carried out
under category 1 containment conditions.
Western blot analysis of the average number
of gD molecules per virion
A fusion protein (gDFc) consisting of the ectodomain of HSV1 gD (amino
acids 1–318) fused to the Fc region of the human IgG was generated as
described in Stura et al. (22). The protein was expressed in Chinese hamster
ovary cells and puriﬁed from tissue culture supernatant by afﬁnity chro-
matography on protein A sepharose. A Western blot analysis of known
numbers of virus particles was carried out in comparison with known
amounts of puriﬁed HSV1 gDFc fusion protein. This analysis was per-
formed on two independently prepared and particle-counted virus stocks.
The Western blots were semiquantiﬁed using a Flowgen ChemiImager 4000
phosphoimager (Flowgen Bioscience, Wilford, UK), and from the data
obtained in the linear region of these histograms it was possible to calculate a
mean value for the number of gD molecules per virion.
FIGURE 2 Representative ﬂuorescence bursts due to single virions in the
two color channels: Coincident events are marked by horizontal bars. The
thresholds used to analyze the data are also indicated (green and black lines).
Note that due to incomplete overlap of the confocal volumes excited by the
red and blue lasers the coincidence detection efﬁciency is;20%, so that not
all bursts are coincident (7). In addition, both unenveloped capsids and light
particles, which do not have a capsid but have a tegument and envelope, will
be present and give rise to ﬂuorescent bursts on only one channel.
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Laser setup
Samples were excited using two laser beams with overlapping focal volumes
of 30%, as described previously (7). A red laser beam (633 nm, He-Ne,
model 25LHP151, Melles Griot, Carlsbad, CA) and blue laser beam (488
nm, argon ion, model 35LAP321-230, Melles Griot) were directed through a
dichroic mirror (FITC/CY5, AHF Analysentechnik, Tu¨bingen, Germany)
and the oil immersion objective (Plan Apo TIRF 603, numerical aperture
1.45, Nikon, Tokyo, Japan) of a TE2000U optical microscope to be focused
into the sample solutions. To achieve maximum overlap of the beams, the
red beam was adjusted to be parallel and the blue beam was tuned to be
slightly convergent (7). Fluorescence was collected by the same objective
and imaged onto a 50-mm pinhole (Newport, Irvine, CA) to reject out of
focus ﬂuorescence and other background. Red and blue ﬂuorescence were
then separated using a second dichroic mirror (585DRLP, Omega Optical
Filters, Brattleboro, VT). Red ﬂuorescence was ﬁltered by a long-pass ﬁlter
with cutoff 565 nm and a band-pass ﬁlter centered at 695 nm (565ALP and
695AF55, Omega Optical Filters), and blue ﬂuorescence was ﬁltered by a
long-pass ﬁlter with cutoff 510 nm and a band-pass ﬁlter centered at 535 nm
(510ALP and 535AF45, Omega Optical Filters). Each color ﬂuorescence
was then focused onto a separate avalanche photodiode (APD) (SPCM
AQR-141, EG&G, Quebec, Canada), and output from the APDs was coupled
to two PC-implemented multi-channel scalar cards (MCS-Plus, Ortec, Oak
Ridge, TN). The synchronous start output of oneMCS card was used to trigger
the second, with negligible time delay between the two cards (7).
Virus measurements
Each virus-antibody preparation was tested separately by placing a 20-ml
drop of the solution on a cover glass above the oil-immersion objective of
the inverted microscope. The droplet was then covered with a 4-mm-high
plastic lid to reduce evaporation and any possible contamination. The
microscope was focused 5 mm into the solution above the glass. The laser
powers at the microscope were 0.391 mW at 633 nm (red) and 1.355 mW at
488 nm (blue). Extremely low laser powers had to be used to keep the count
rates within the working range of the APD apparatus (up to MHz). The laser
power is ,1 kWcm2 so that saturation effects are negligible. Upon
illumination of the sample, the droplet was scanned at a rate of ;1 mm s1
over the objective by slowly adjusting the position of the stage, resulting in
virus particles in the solution crossing the focal volume. At these low
concentrations we found no evidence of two or more virions in the probe
volume at one time. The number of photons incident in intervals of 1 ms
upon each APD were counted by multi-channel scalar cards. This infor-
mation was stored in ﬁles 10,000 intervals long. For each virus sample
;100–200 ﬁles of data were obtained, representing 25 min of data ac-
quisition time on average. The thresholds used to analyze the data were the
averages for the two channels of those calculated for each set of data by
optimizing the association quotient (the ratio of the signiﬁcant rate of
coincident events to the total rate of events) as a function of the thresholds
(23). These were 25 per interval in the red channel and 17 per interval in the
blue channel.
Data analysis
For each coincident event the ratio of the red count per interval to the blue
count per interval was calculated, and normalized histograms were formed
of the logarithms (to base e) of these numbers. There were typically 10,000
coincident events per sample analyzed. Taking logarithms of the ratios
before forming the histograms ensures that homogenous subpopulations
appear as Gaussian distributions in the probability density function (10). The
three histograms for each type of sample were then averaged together
and the resultant histograms ﬁtted by Gaussian peaks. The central positions
and widths of these peaks were then used to calculate the relative size and
variation of the populations of tegument and envelope proteins as follows:
The average brightnesses of coincident events (100 photons per interval
in the red channel; 124 photons per interval in the blue channel) were used to
estimate the proportion of the width of the peaks due to photon shot noise
according to the formula
sphoton ¼
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In this formula the parameter K is the square of the factor by which this
contribution to the peak width exceeds that due to shot noise alone (10). For
this work this parameter is set equal to unity because the extremely low laser
powers used in these experiments ensure that all photophysical paths apart
from ﬂuorescence emission from the excited state are negligible. This means
that the distributions of the dyes’ ﬂuorescence emissions from each point in
the confocal probe volume are expected to be perfectly Poissonian. At the
brightnesses speciﬁed above, the shot noise width is estimated to be 0.1344.
The actual photon shot noise will be slightly higher than this estimate
because of imperfect beam overlap. This may be accurately characterized in
the future by using a virion strain with dual-labeled capsids.
The width of the VP26-gD peak after subtraction of the width estimated
to be due to shot noise was used to estimate the width of the other peaks due
to variation in the amount of gD envelope protein in each virion. The widths
of the VP22-gD and VP16-gD peaks after subtraction of both the shot noise
width and the gD width were then attributed to variation in the levels of
VP22 and VP16 expressed in these strains of the virus. Thus, the slight
underestimation of photon shot noise mentioned above does not affect the
variation derived for VP22 and VP16, and this means that the calculated
variation in gD number is marginally overestimated.
All of the virus data were taken at the same laser powers except, to
explore the variation of the data with these parameters, two of the VP26-gD
measurements were performed at higher combinations of laser powers (0.40
mW at 633 nm (red) and 1.50 mW at 488 nm (blue), and 0.50 mW at 633 nm
(red), and 1.51 mW at 488 nm (blue)) and the photon counts of coincident
events for these sets of data were rescaled: For each coincident event, the
individual photon count in each channel was multiplied by the ratio of the
average brightness of coincident events for that sample to the average
brightness of coincident events for the VP26 sample measured with the
lower laser powers. This simple rescaling procedure immediately resulted in
good overlap of the histograms for the VP26 data (Fig. 3), indicating that the
technique is resilient to variations in laser power.
Estimation of individual brightnesses
To estimate the brightnesses of the individual ﬂuorophores, data were
collected from 10- and 100-pM solutions of GFP, YFP, and LP2-Alexa-647
in the same buffer solution as the main experiments. The presence of
formaldehyde was found to have a negligible effect on the brightnesses
measured. The laser powers at the microscope were 47.3 mWat 633 nm (red)
and 209 mW at 488 nm (blue). The brightnesses were assumed to scale
linearly with laser power. This is a reasonable assumption because the laser
powers were low enough not to saturate the ﬂuorophores for the brightness
calibration measurements and very signiﬁcantly lower than would have been
needed to do this in the virus experiments. We also assumed that the
variation in diffusion time between the different species (all approximately
the same size) would be small and therefore would not affect the
brightnesses. The thresholds used to analyze these data were those calculated
for the virus data, corrected by a constant arbitrary scaling factor (0.005) and
multiplied by the ratio of laser powers used in the brightness calibration to
the virus measurement (yielding 15 per interval in the red channel and 13
per interval in the blue channel). The brightnesses measured in this
way were 24.0 per interval for YFP, 23.7 per interval for GFP (on average
23.9 per interval for YFP and GFP), and 50.2 per interval for the Alexa-
647-labeled LP2 antibody. Therefore the expected brightnesses at the
laser powers used in the virus experiments were, for a single ﬂuo-
rescent protein,23:93 ½1:355=209  0:155and for a single antibody,
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50:23 ½0:391=47:3  0:415: The ratio red/blue of these brightnesses was
therefore found to be 2.68, allowing the position of the peaks in the ratio
histograms to be quantitatively related to the numbers of proteins.
RESULTS
Ratio histograms for VP26, VP22, and VP16
In these experiments multiple copies of the individual
proteins that make up a virion are produced in the host cell
and then assembled together to produce complete virions that
are then analyzed. Plaque forming unit (pfu) ratios were
determined by comparing the concentration of virus particles
in each virus stock with the concentration of infectious
virions as measured by plaque assays giving a particle/pfu
ratio of;20 (24). There are;100 pfu/cell released (data not
shown), which equates to;2000 virions per cell. This means
that any measured variation is not due to differences in
expression levels but differences in assembly. The ratio
histograms and average ﬁts for the repeats of experiments
performed on viruses expressing VP26yfp, VP22gfp, and
VP16gfp are shown in Fig. 3. In all cases the virions were
labeled with antibody to gD (LP2) that was tagged with a red
ﬂuorophore. Each sample was ﬁxed in 1% formaldehyde.
Having added a droplet of the solution to a microscope slide,
the sample was scanned through the two overlapped laser
beams for analysis. This raised the encounter rate of the
virions with the probe volume by more than two orders of
magnitude compared with the encounter rate achievable by
their free diffusion without scanning. This method showed
discrete bursts of ﬂuorescence on both channels above a low
background, as shown in Fig. 2. Any aggregation of the virus
sample was readily detectable since this resulted in an
absence of bursts and then one much longer intense burst.
Data were only taken when discrete bursts were detected.
The results for different preparations are highly reproducible,
as shown by the close agreement of histograms correspond-
ing to different preparations of the same types of sample in
Fig. 3. The ﬁts to all the repeats for these experiments are
overlaid and shown in the lower right-hand panel of this
ﬁgure. This shows small differences in peak position but
marked differences between the widths of the histograms.
To convert these histograms into the mean number of
proteins and their variation, we assumed that the number of
capsid proteins was the same for all virions, with 900 copies
of VP26 per virion (25–27). The widths of the histograms are
then due to photon shot noise and the variation in the
numbers of the tegument proteins and envelope gD antigen.
In principle the variation in the number of ﬂuorophores on
each antibody could affect our results. However since 330
antibodies bind on average to a virion, as shown below, this
variation is reduced by a factor of (330)0.5, i.e., a factor of 18,
and hence makes a negligible contribution to the measured
widths. We also needed to measure the relative brightness of
EGFP, EYFP, and the anti-gD antibodies in a separate
control experiment using individual proteins (see Materials
and Methods for details) and assume that the relative
brightness did not change when these components are in the
FIGURE 3 Logarithmic ratio histo-
grams of individual virions for labeled
VP26, VP16, and VP22. The lower right
panel shows an overlay of the ﬁtted
peaks, shown as diamond symbols in
the other three panels.
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virus and scaled linearly with laser power. This allows us to
convert the peak position in the histogram into relative
number of proteins. As shown below, these assumptions give
the same mean number of proteins per virion as those
obtained by other methods. We can then calculate the var-
iation in protein copy number. The results of this analysis are
shown in Table 1.
Estimation of the number of molecules present in
HSV1 virions
We used two different methods to independently measure the
number of antibody-accessible gDs per virion for compar-
ison with the results obtained above and to validate the
assumptions made. We ﬁrst used single-color ﬂuorescence to
study the binding of an Alexa-647-labeled antibody (LP2)
bound to HSV virions freely diffusing in solution. Increasing
concentrations of antibody were added to a solution of
virions, and the average intensity of the top 1000 ﬂuores-
cence bursts was calculated for each concentration. This
intensity reﬂects the average number of labeled LP2 mole-
cules bound to individual virions. The average intensity
increased with the antibody/virus molar ratio until it reached
a plateau above a ratio of 300:1 (Fig. 4). Note that the photon
counting is still in a linear regime for the brightest virions
detected. This result indicates that the maximum number of
sites available for LP2 on the HSV1 envelope is ;300. Two
control experiments conﬁrmed that the observed LP2
binding to gD is speciﬁc. First, HSV1 virions were incubated
with pooled Alexa-647-labeled rabbit IgG. Second, a gD-
negative mutant of HSV1 (28) was incubated with the LP2
antibody. For both control experiments, 10 pM virus and
1 nM antibody were tested under identical experimental
conditions to those used for analyzing LP2 binding to gD-
positive virions, and in both cases we detected no brighter
ﬂuorescence bursts than those for the antibody-alone back-
ground (data not shown).
Second an independent measurement of the number of gD
molecules present in HSV virions was made by comparing
the intensity of a known quantity of puriﬁed gD to the
intensity of the gD band from a preparation of virions in a
Western blot analysis (Fig. 5). The signal obtained from 15.6
ng of gDFc was equivalent to the signal from ;3.3 3 108
virus particles in experiment A and ;5 3 108 virions in
experiment B. Using the molecular weight of the gDFc
fusion protein whose amino acid sequence is known (1.5 3
105 amu), we estimate that HSV virions contain 378
(experiment A) or 250 (experiment B) molecules of gD per
particle, giving a mean value of 310. The agreement between
these values for the Western blot and ﬂuorescence experi-
ments implies that antibody binding to gD is monovalent and
that the relative ﬂuorescence intensity measured from single
virions is an accurate indicator of the relative number of gD
molecules per virion. Both these results are in agreement
with the value obtained from the ratio histograms.
DISCUSSION
Our studies have focused largely on using viruses expressing
ﬂuorophore-tagged virion components. Despite the addition
of GFP or YFP tags to the VP26 capsid protein or to VP22 or
VP16 tegument proteins, these recombinant viruses replicate
just as efﬁciently as wild-type nontagged HSV1 (14–16).
This strongly supports the view that they incorporate these
tagged proteins into the virus particle as efﬁciently as nontagged
versions and are therefore valid reagents to use as a model
system for studying populations of wild-type HSV. Our
technique provides quantitative information about viral
protein copy number in these viruses that is consistent with
measurements that we have made using the more traditional
Western blot method that does not use GFP tags. A previous
report claimed that there are 3.4 3 104 gD molecules per
HSV virion (29). However, this seems an unlikely value
since this number of gD molecules would weigh more than
the mass of an entire HSV virion. The assumption that the
ﬂuorescence intensity of the GFP is not altered in the virus is
TABLE 1 Variation in protein copy number
Protein Copy number Nlow ¼ ems Ncenter ¼ em Nhigh ¼ em1s
VP26 90034 1:00 900 900 900
VP22 84534 0:53 450 845 1585
VP16 79534 0:62 495 795 1280
gD 33534 0:70 235 335 480
The distributions of copy number of the proteins over the populations of
viruses are justiﬁably assumed to be lognormal (see Discussion). Such
distributions can be summarized by the following statistics: Nlow ¼ ems;
Ncenter ¼ em; Nhigh ¼ em1s; where m and s are the mean and standard de-
viation of the distribution log(N), respectively. This is equivalent to quoting
the statistic N ¼ em 34 es:
FIGURE 4 Average ﬂuorescence photon counts per 10 ms for individual
HSV1 virions as a function of the molar ratio of ﬂuorophore-labeled LP2-
IgG antibody to HSV1. All measurements were performed at a concentration
of 10 pM HSV1. The number of counts increases linearly and then plateaus
at a molar ratio of ;300. A threshold 10 times higher than background was
used for all points. The error bars indicate one standard deviation.
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justiﬁed by the agreement with the Western blot analysis and
by the protective barrel structure of the ﬂuorophore, which
makes it environmentally insensitive. Our two-color coinci-
dent detection method also allows us to distinguish between
antibody bound to virus and free antibody so that the method
does not require dual expression of GFP tagged proteins
and provides information about the number of antibody-
accessible binding sites, an important parameter for inter-
pretation of antibody-mediated neutralization. All the gD
sites appear accessible to the LP2 antibodies.
Important to inferences about the assembly of the virus by
performing virion-by-virion analysis, this technique allows
the calculation of variations in copy numbers of the envelope
glycoproteins (and the tegument proteins), neither of which
has been measured to date. The variation in gD number
measured here was 235–480. This is in reasonable agreement
with a measurement of the variation in the number of
glycoprotein spikes (2), 600–750, which was performed on a
much smaller number of virus particles and could not
identify the glycoproteins present. It also suggests that not all
the glycoprotein spikes contain gD. The data we present also
indicate that there is large variation in the copy numbers of
VP16 and VP22 tegument proteins between individual HSV
virions, in agreement with del Rio et al. (5). Furthermore, our
estimates for the absolute copy numbers are comparable to pre-
vious estimates of the average numbers of VP16 and VP22
proteins of between 1000–1500 per virion, although the
methods used (i.e., radiochemical labeling and Coomassie
FIGURE 5 Quantiﬁcation of the amount of gD per
HSV virion. Two independently prepared stocks (A
and B) of HSV1 virions were analyzed by Western blot
using an antibody to gD. The top panel in each case
shows the Western blot, and the histograms show the
densitometry readings for the range of concentrations
of gDFc protein compared to the range of dilutions of
virions.
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staining) to determine these earlier values reportedly suffered
from some inherent sources of error (30).
Our data indicate that the distributions of tegument
proteins are highly skewed and approximately lognormal,
with signiﬁcant standard deviations in the statistic log(N).
Such distributions are common in biology because they
result from multiplicative processes, the effective multipli-
cation and division of a range of independently distributed
factors (31). This is a purely statistical effect that is anal-
ogous to the case proved by the central limit theorem, in
which the addition and subtraction of independent variables
results in a Gaussian distribution. For the case of tegument
proteins, there are many possibilities for the multiplicative
factors that include, for example, the rates of transcription
and translation and the rates of diffusion or transport through
the cytoplasm and incorporation into vesicles, etc. The
distribution of VP26 capsid protein, on the other hand, is
highly homogenous and even the variation of the gD copy
number only results in relatively small widths of the his-
tograms in Fig. 3 (top left panel). This is, of course, expected
and is because the process of virion formation is evidently
nucleated by the formation of complete capsids. This inter-
pretation of our results broadly agrees with del Rio et al. (5),
who ﬁt a histogram of relative ﬂuorescence emission from
individual puriﬁed virions expressing GFP-VP22 with a
Poisson distribution, rather than the Gaussian distribution
used for control virions expressing ﬂuorescently tagged
VP26. They conclude that incorporation of VP22 into virions
is much more heterogeneous than incorporation of the capsid
protein VP26.
This technique offers the potential for addressing a
number of fundamental questions relating to virus infectiv-
ity, antibody neutralization mechanisms, and virion assem-
bly. We have demonstrated the feasibility of the method by
measuring the number of an envelope glycoprotein (gD) and
two tegument proteins (VP16 and VP22) in individual HSV1
virus particles and the variation in the copy number of these
proteins for the ﬁrst time, to our knowledge. This may now
be extended to determine the relative stoichiometries and
variation in copy numbers of many of the other herpesvirus
virion components in different populations of viruses. As-
sessing the extent to which such compositional heterogeneity
exists in preparations of different HSV strains in populations
of virions produced by different cell types (e.g., epithelial
cells and neurons) and in clinical isolates of HSV will
provide insight into the biological functions of virion
components in HSV pathogenesis. Furthermore, the mor-
phogenesis of herpesviruses involves multiple, yet still
poorly understood, interactions between tegument proteins
and glycoproteins (32). The application of two-color ﬂuo-
rescence analysis to examine compositional variation in
viruses that lack speciﬁc virion components that are thought
to play a role in virus egress is likely to shed further light on
these complex assembly routes. Finally, the ability to detect
and measure both envelope proteins and structural proteins
of individual virus particles can now also be applied to the
study of populations of other clinically important virus patho-
gens, such as inﬂuenza virus and human immunodeﬁciency
virus.
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